Skip to main content

FOLD Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Amicus Therapeutics Inc. News

Amicus Therapeutics Stock Rises; Sells Unit Stake in SPAC Deal

Amicus is selling a stake in its gene-therapy unit to ARYA Sciences Acquisition IV, a special purpose acquisition company sponsored by Perceptive Advisors.

HubSpot, Twitter, Sonos: Latest Upgrades and Downgrades

TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Estee Lauder, Twitter and Uber.

Amicus Reports Disappointing Tests Results for Pompe Disease Drug

Amicus tanks as analysts downgrade it after the company reported disappointing test results for its Pompe disease drug.

Fear of Big Sellers: Cramer's 'Mad Money' Recap

Jim Cramer says investors need to consider the bear the motivation, and they need to consider the big sellers they'll have to outrun.

FedEx, Funko, Amicus Therapeutics: 'Mad Money' Lightning Round

Jim Cramer takes a look at FedEx, Funko, Amicus Therapeutics, Turning Point Brands, Sirius XM Radio, and more.

Breaking News

Las Vegas Strip May Lose a Major Sports Franchise

Sin City usually gets what it wants. That may not happen this time.

Steve Jobs Gets Posthumous Award From President Joe Biden

Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.

Target Has a Surprising New Idea For Cereal Fans

This throwback will excite fans who fondly remember cereals from their childhoods.

TikTok Faces a New Major Threat

The popular short-form social media company is in the hot seat once again in the U.S.